551 related articles for article (PubMed ID: 33958804)
41. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner.
Wong MY; Lewis M; Doherty JJ; Shi Y; Cashikar AG; Amelianchik A; Tymchuk S; Sullivan PM; Qian M; Covey DF; Petsko GA; Holtzman DM; Paul SM; Luo W
J Neuroinflammation; 2020 Jun; 17(1):192. PubMed ID: 32552741
[TBL] [Abstract][Full Text] [Related]
42. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
[TBL] [Abstract][Full Text] [Related]
43. Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.
Usenovic M; Niroomand S; Drolet RE; Yao L; Gaspar RC; Hatcher NG; Schachter J; Renger JJ; Parmentier-Batteur S
J Neurosci; 2015 Oct; 35(42):14234-50. PubMed ID: 26490863
[TBL] [Abstract][Full Text] [Related]
44. Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer's disease pathology in a mouse model.
Wang ZH; Xia Y; Wu Z; Kang SS; Zhang JC; Liu P; Liu X; Song W; Huin V; Dhaenens CM; Yu SP; Wang XC; Ye K
Prog Neurobiol; 2022 Feb; 209():102212. PubMed ID: 34958873
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein E gene and Alzheimer's disease: is tau the link?
Lovestone S; Anderton B; Betts J; Dayanandan R; Gibb G; Ljungberg C; Pearce J
Biochem Soc Symp; 2001; (67):111-20. PubMed ID: 11447827
[TBL] [Abstract][Full Text] [Related]
46. APOE and Alzheimer's disease: Pathologic clues from transgenic Drosophila melanogaster.
Haddadi M; Haghi M; Rezaei N; Kiani Z; Akkülah T; Celik A
Arch Gerontol Geriatr; 2024 Aug; 123():105420. PubMed ID: 38537387
[TBL] [Abstract][Full Text] [Related]
47. Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.
Li Z; Del-Aguila JL; Dube U; Budde J; Martinez R; Black K; Xiao Q; Cairns NJ; ; Dougherty JD; Lee JM; Morris JC; Bateman RJ; Karch CM; Cruchaga C; Harari O
Genome Med; 2018 Jun; 10(1):43. PubMed ID: 29880032
[TBL] [Abstract][Full Text] [Related]
48. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
[TBL] [Abstract][Full Text] [Related]
49. Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS.
Xu Q; Walker D; Bernardo A; Brodbeck J; Balestra ME; Huang Y
J Neurosci; 2008 Feb; 28(6):1452-9. PubMed ID: 18256266
[TBL] [Abstract][Full Text] [Related]
50. EFAD transgenic mice as a human
Tai LM; Balu D; Avila-Munoz E; Abdullah L; Thomas R; Collins N; Valencia-Olvera AC; LaDu MJ
J Lipid Res; 2017 Sep; 58(9):1733-1755. PubMed ID: 28389477
[TBL] [Abstract][Full Text] [Related]
51. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.
Lombardi VR; García M; Cacabelos R
J Neurosci Res; 1998 Nov; 54(4):539-53. PubMed ID: 9822164
[TBL] [Abstract][Full Text] [Related]
52. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
53. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
[TBL] [Abstract][Full Text] [Related]
54. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging.
Ishunina TA; Swaab DF
Exp Neurol; 2003 Sep; 183(1):159-72. PubMed ID: 12957499
[TBL] [Abstract][Full Text] [Related]
55. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
56. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein.
Nathan BP; Jiang Y; Wong GK; Shen F; Brewer GJ; Struble RG
Brain Res; 2002 Feb; 928(1-2):96-105. PubMed ID: 11844476
[TBL] [Abstract][Full Text] [Related]
58. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice.
Osorio C; Sullivan PM; He DN; Mace BE; Ervin JF; Strittmatter WJ; Alzate O
Neurobiol Aging; 2007 Dec; 28(12):1853-62. PubMed ID: 17050040
[TBL] [Abstract][Full Text] [Related]
59. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
[TBL] [Abstract][Full Text] [Related]
60. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
